Matches in Nanopublications for { ?s ?p "[Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP331517.RAZyeIKFA_tXKSlQWUhOYoaoKdFZQTPmhIFk0YmAoK3JI130_assertion description "[Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331517.RAZyeIKFA_tXKSlQWUhOYoaoKdFZQTPmhIFk0YmAoK3JI130_provenance.
- NP350157.RAiaoJ8Vbg2JQ4ORwi8iCxJTDwkhH5D2HzU2dlzx39H6Y130_assertion description "[Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350157.RAiaoJ8Vbg2JQ4ORwi8iCxJTDwkhH5D2HzU2dlzx39H6Y130_provenance.
- NP362984.RACvcTfuhTm2KfexwdbQ2HgV6-dPKFWK55heIp5AKKXPo130_assertion description "[Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362984.RACvcTfuhTm2KfexwdbQ2HgV6-dPKFWK55heIp5AKKXPo130_provenance.
- NP406713.RAH3k0_nd11kxB90M6xrNOrXgk7JOU_1lpqoL7TblWmdw130_assertion description "[Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406713.RAH3k0_nd11kxB90M6xrNOrXgk7JOU_1lpqoL7TblWmdw130_provenance.
- NP656241.RAxUo0kd13717Dq0wpmhl3bb9k_AfTXcVPe2ivnzzdnHo130_assertion description "[Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656241.RAxUo0kd13717Dq0wpmhl3bb9k_AfTXcVPe2ivnzzdnHo130_provenance.